Companies: 10,795·Total market cap: $144.5T
Olink Holding AB (publ)

Olink Holding AB (publ)

OLKNASDAQHealthcare
$26.08
+$0.08(+0.31%)
Market Cap$3.2B
P/E Ratio
52W High$26.09
52W Low$14.1
Overview

Olink Holding AB (publ) (OLK) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

olk · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Olink Holding AB (publ) (OLK) measures how much investors pay for each dollar of the company's trailing earnings. OLK's current PE ratio of N/A is calculated by dividing its stock price of $26.08 by its TTM earnings per share of -$0.26.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
521.60x
FY2026 est. EPS $0.05
Based on 1 analyst
EPS (TTM)
-$0.26
TTM · diluted EPS
PEG Ratio
1.34
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Olink Holding AB (publ) SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2023 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Olink Holding AB (publ)
Olink Holding AB (publ)You
OLK
$3.2BN/A-$0.26
Amedisys, Inc.
Amedisys, Inc.
AMED
$3.3B68.71x$1.32
Axonics, Inc.
Axonics, Inc.
AXNX
$3.6BN/A-$0.12
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc.
CBAY
$3.7BN/A-$0.99
MorphoSys AG
MorphoSys AG
MOR
$2.9BN/A-$1.38
Morphic Holding, Inc.
Morphic Holding, Inc.
MORF
$2.9BN/A-$3.59
1Life Healthcare, Inc.
1Life Healthcare, Inc.
ONEM
$3.4BN/A-$2.02

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-0.26
2022-12-31
FY2022
$-0.11
2021-12-31
FY2021
$-0.39
2020-12-31
FY2020
$-0.06
2019-12-31
FY2019
$-0.15

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Olink Holding AB (publ) (OLK) measures how much investors pay for each dollar of the company's trailing earnings. OLK's current PE ratio of N/A is calculated by dividing its stock price of $26.08 by its TTM earnings per share of -$0.26.

PE Ratio = Stock Price ÷ EPS (TTM)
= $26.08 ÷ -$0.26 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

OLK pe ratio · 6 questions

OLK's current PE ratio is N/A as of 2026-06-09, based on a stock price of $26.08 and TTM EPS of -$0.26. Data sourced from Financial Modeling Prep via OLK's SEC 10-K and 10-Q filings.

OLK PE ratioWhat is OLK PE ratioCurrent PE ratio of OLKOLK PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Olink Holding AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09